Singapore: Medizone International, developers of AsepticSure, a unique room disinfection system, has been granted a pate...
Singapore: Fujitsu Laboratories, Europe; Fujitsu Asia and National University of Singapore (NUS), have inked a collabora...
Singapore: Pharmaceutical Product Development (PPD), a contract research organization providing drug discovery, developm...
Singapore: The Skin Research Institute of Singapore has announced that the Agency for Science Technology and Research (A...
Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Scienc...
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...
Singapore: Researchers from the Institute of Bioengineering and Nanotechnology (IBN) and IBM Research unveiled the firs...
Singapore: National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Departme...
Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corpo...
Singapore: Professor Wang Yue from A*STAR's Institute of Molecular and Cell Biology (IMCB) received the President's Scie...
Singapore: Eastern Health Alliance, the regional health system for eastern Singapore, and IHiS is recognized with top As...
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...
Singapore: Scientists at A*Star's Genome Institute of Singapore (GIS) have discovered an unusual gene that controls the ...
Singapore: pSivida, which is into developing sustained release, drug delivery products for treatment of back-of-the-eye ...
Singapore: Medical technology companies may be losing their competitive edge and are in need of a different approach to ...
Singapore: A*STAR's Institute of Medical Biology and the British High Commission are jointly holding the first Translati...
Singapore: A research study from Nanyang Technological University (NTU) has yielded important breakthroughs on how the ...
Singapore: Mesoblast announced that US FDA is in agreement for the supply of its proprietary Mesenchymal Precursor Cell...
